OX
Oxygenta Pharmaceutical Ltd.
OXYGENTAPH.BO · BSE
₹55.88 +3.87% (+₹2.08)
1M -17.13%
Market Cap ₹2.07B
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
80 /100
Cheap P/S 1.83x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 53.91%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 0.78%
Net margin 15.55%
FCF margin 40.10%
Quality
17 /100
Poor ROIC 20.65%
ROA 14.68%
Asset turnover 0.94x
Debt
5 /100
High Current ratio 0.60x
Int. coverage -3.70x
Debt/Equity N/A
Stability
18 /100
Unstable Beta 0.47x
Rev. volatility 93.23%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OXYGENTAPH.BO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Prasad Reddy Battinapatla
Employees
170
Headquarters
Hyderabad